Pädiatrie pp 1215-1246 | Cite as

Thrombozyten und Gerinnung

  • R. Schneppenheim
  • F. Bergmann

Zusammenfassung

An den Aufgaben der Hämostase, die Fließfähigkeit des Blutes optimal zu erhalten, dabei jedoch Blutverluste nach Verletzungen zu verhindern, sind im wesentlichen 3 Systeme beteiligt:
  • das Gefäßsystem selbst, ausgekleidet mit Endothel, das den Durchtritt von Wasser, Ionen, Sauerstoff, CO2, Nährstoffen, Stoffwechselprodukten, Proteinen und zellulären Komponenten ermöglichen, auf der anderen Seite jedoch den Austritt von Blut verhindern soll,

  • die Blutplättchen oder Thrombozyten und

  • die plasmatische Gerinnung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80: 1998–2005PubMedGoogle Scholar
  2. Aschka I, Aumann V, Bergmann F et al. (1996) Prevalence of factor V Leiden in children with thrombo-embolism. Eur J Pediatr 155:1009–1014PubMedCrossRefGoogle Scholar
  3. Aster RH (1995) Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 332:1374–1376PubMedCrossRefGoogle Scholar
  4. Bertina RM (1998) The prothrombin 20210 G to A variation and thrombosis. Curr Opin Hematol 5: 339–342PubMedCrossRefGoogle Scholar
  5. Bertina RM, Koeleman BP, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C [see comments]. Nature 369: 64–67PubMedCrossRefGoogle Scholar
  6. Bick RL (1998) Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemost 24:3–18PubMedCrossRefGoogle Scholar
  7. Brenner B, Sanchez-Vega B, Wu SM, Lanir N, Stafford DW, Solera J (1998) A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 92:4554–4559PubMedGoogle Scholar
  8. Broze GJ Jr (1995) Tissue factor pathway inhibitor. Thromb Haemost 74: 90–93PubMedGoogle Scholar
  9. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EG (1997) Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 78:151–160PubMedGoogle Scholar
  10. Cooper DN, Millar DS, Wacey A, Pemberton S, Tuddenham EG (1997) Inherited factor X deficiency: molecular genetics and pathophysiology. Thromb Haemost 78:161–172PubMedGoogle Scholar
  11. Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofac-tor to activated protein C [see comments], Proc Natl Acad Sci U S A 90: 1004–1008PubMedCrossRefPubMedCentralGoogle Scholar
  12. David M, Andrew M (1993) Venous thromboembolic complications in children. J Pediatr 123: 337–346PubMedCrossRefGoogle Scholar
  13. David M, Manco-Johnson M, Andrew M (1995) Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74: 791–792PubMedGoogle Scholar
  14. Engesser L, Broekmans AW, Briet E, Brommer EJP, Bertina RM (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106: 677–682PubMedCrossRefGoogle Scholar
  15. Fisher S, Rikover M, Naor S (1966) Factor 13 deficiency with severe hemorrhagic diathesis. Blood 28: 34–39PubMedGoogle Scholar
  16. Furie B, Furie BC (1990) Molecular basis of vitamin K-dependent gamma- carboxylation. Blood 75:1753–1762PubMedGoogle Scholar
  17. George JN, Woolf SH, Raskob GE et al. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]. Blood 88:3–40PubMedGoogle Scholar
  18. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370–1373PubMedCrossRefPubMedCentralGoogle Scholar
  19. Ingram GIC (1997) The history of haemophilia. Haemophilia 3 (Suppl 1): 5–15Google Scholar
  20. Lillicrap D (1998) The molecular basis of haemophilia B. Haemophilia 4: 350–357PubMedCrossRefGoogle Scholar
  21. Mammen EF (1983) Factor V deficiency. Semin Thromb Hemost 9:1–72PubMedCrossRefGoogle Scholar
  22. Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339: 245–253PubMedCrossRefGoogle Scholar
  23. Mannucci PM (1998) Haemophilia treatment protocols around the world: towards a consensus. Haemophilia 4: 421PubMedCrossRefGoogle Scholar
  24. Mannucci PM (1998) Treatment of von Willebrand disease. Haemophilia 4: 661–664PubMedCrossRefGoogle Scholar
  25. McDonagh J, Carrell N, Lee MH (1994) Dysfibrinogenemia and other disorders of fibrinogen structure and function. In: Colman RW, Hirsh J, Marder VJ, Salzman JB (eds) Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. Lippincott, Philadelphia, pp 314–334Google Scholar
  26. Peake I (1998) The molecular basis of haemophilia A. Haemophilia 4: 346–349PubMedCrossRefGoogle Scholar
  27. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN (1985) Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 65: 719–724PubMedGoogle Scholar
  28. Remond-O’Donnell E, Rosen FS, Kenney DM (1996) Defects in Wiskott-Aldrich syndrome blood cells. Blood 87: 2621–2631Google Scholar
  29. Ruggeri ZM (1991) Structure and function of von Willebrand factor: relationship to von Willebrand’s disease. Mayo Clin Proc 66: 847–861PubMedCrossRefGoogle Scholar
  30. Schneppenheim R, Thomas KB, Sutor AH (1995) Von Willebrand disease in childhood. Semin Thromb Hemost 21: 261–275PubMedCrossRefGoogle Scholar
  31. Sutor AH (1995) Thrombocytosis in childhood. Semin Thromb He-most 21: 330–339CrossRefGoogle Scholar
  32. Triplett DA (1998) Many faces of lupus anticoagulants. Lupus 7 (Suppl 2): 18–22CrossRefGoogle Scholar
  33. Tuddenham EG, Pemberton S, Cooper DN (1995) Inherited factor VII deficiency: genetics and molecular pathology. Thromb Haemost 74: 313–321PubMedGoogle Scholar
  34. Wood AJJ (1998) Thrombopoietin. N Engl J Med 339: 746–754CrossRefGoogle Scholar
  35. Zimmerman TS, Ratnoff OD, Powell AE (1971) Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand’s dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 50:244–254PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • R. Schneppenheim
  • F. Bergmann

There are no affiliations available

Personalised recommendations